The AMA announced that the CPT® code set is being updated by the CPT Editorial Panel to include vaccine and administration codes that are unique to the COVID-19 vaccine candidate under development by Janssen Pharmaceutica, a division of Johnson & Johnson.
Read More
By Linda Fischer – The ongoing stressors of COVID-19 surges, staffing shortages, and hospitals filled beyond typical capacity have converged over the past year to make efficient care coordination more important than ever. Now, as healthcare workers also prepare for the additional difficulties that come with flu season…
By Drew Ivan – In December 2020, the FDA approved the Pfizer/BioNTech vaccine for emergency use in the U.S., making it the fastest vaccine to be brought to market. Approval of the vaccine has come just 10 months after the first COVID-19 cases were reported in the U.S. A second vaccine, from Moderna, also recently gained FDA approval.
By Daniel Cidon – The race to rollout a COVID-19 vaccine presents a number of challenges, from safety and efficacy, to storage and distribution. Once a vaccine is approved, the industry must have a robust strategy in place to manage coronavirus immunizations effectively.
By Liz Szabo – With millions of lives on the line, researchers have been working at an unprecedented pace to develop a COVID-19 vaccine. But that speed — and some widely touted breakthroughs — belie the enormous complexity and potential risks involved.
New On Demand Dr. Nick: The Incrementalist: With guest Richard Pan, MD, MPH, a pediatrician and California State Senator. He has been a leading advocate of increasing the health of everyone and raising California’s vaccination rates, sadly making him a target for online harassment and in-person assaults by conspiracy theorists and anti-vaccine groups.
Patients could save time and money if federal law is reformed to allow pharmacists to administer all CDC recommended vaccines, a new study released by…